Status:
COMPLETED
Preoperative Risk Score for Postoperative Right Ventricular Dysfunction in Adult Cardiac Surgery
Lead Sponsor:
Fondazione Policlinico Universitario Campus Bio-Medico
Conditions:
Right Ventricular Dysfunction
Eligibility:
All Genders
18+ years
Brief Summary
Right ventricular dysfunction (RVD) is common following cardiac surgery, and it is characterised by impaired right ventricular function that can lead to decreased cardiac output and hemodynamic instab...
Detailed Description
Postoperative RVD will be defined as: \- Echocardiographic parameters suggestive of RVD (at least 2 out of 3): TAPSE \< 16 mmHg; right ventricular fractional area change (RVFAC) \< 35%; right ventric...
Eligibility Criteria
Inclusion
- age \> 18 years
- elective or urgent cardiac surgery at Campus BioMedico between January 2016 to December 2023
- postoperative echocardiogram execution
- ASA class I-IV
Exclusion
- age \< 18 years
- inotropic therapy at the time of surgery
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06539000
Start Date
October 1 2024
End Date
December 31 2025
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Lazio, Italy, 00128